Atlas Trials

Study to Investigate Pregnancy Outcomes in Female Participants Exposed to Subcutaneous (SC) Peginterferon Beta-1a and Intramuscular (IM) Interferon Beta-1a Reported in a German Participant Support Program

Clinical trial NCT04655222 · COMPLETED

Trial details

NCT number
NCT04655222
Sponsor
Biogen
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Start date
2021-04-30
Primary completion
2021-10-15
Enrollment
470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.